R35 Administrative Supplements for Equipment: Regulation of alternative splicing during epithelial-mesenchymal transition
R35 设备管理补充:上皮-间质转化过程中选择性剪接的调节
基本信息
- 批准号:10797795
- 负责人:
- 金额:$ 7.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAlternative SplicingBioinformaticsBiologicalCD44 geneCellsCellular biologyDevelopmentDevelopmental ProcessDiseaseEpitheliumEquipmentFibrosisGenesGoalsMammalsMesenchymalMessenger RNAMolecularNeoplasm MetastasisPhenotypePhosphotransferasesProtein IsoformsRNARNA SplicingRNA-Binding ProteinsRegulationResearchShapesSignal TransductionSystemTimeTissuesTranscriptWorkcausal variantcell motilityexperimental analysisinsightmRNA Precursorprograms
项目摘要
ABSTRACT
Alternative splicing of pre-mRNA enables a gene to give rise to multiple distinct mRNA transcripts,
yielding protein isoforms with different, even opposing, functions. The long-term goal of our research is to
understand the molecular mechanisms and function of alternative splicing on biological activities. The focus of
this proposal is to investigate the regulation of alternative splicing in epithelial-mesenchymal transition (EMT).
EMT is an essential developmental process that allows cells to change from a tightly packed cobble-stone-like
epithelial cellular state to a motile and spindle-shaped mesenchymal cellular state. When abnormally activated,
EMT promotes many types of diseases, including tissue fibrosis and cancer metastasis. Through working at the
intersection of RNA splicing and cell biology, my lab has made several important findings connecting RNA
regulation and EMT. Our work revealed, for the first time, that splice isoform switching of the CD44 gene causally
controls EMT. By manipulating CD44 alternative splicing, we were able to convert cells between the epithelial
and mesenchymal states. We have also identified the RNA-binding protein (RBP) hnRNPM as a critical splicing
factor that promotes EMT through the regulation of alternative splicing. These results suggest that RNA splicing
regulation could serve as an important mechanism that provides cellular plasticity. By shifting the programs of
alternative splicing, cells are able to convert between the epithelial and mesenchymal cellular states. This
capacity of reversing phenotypes is important for normal developmental EMT, as well as for cancer metastasis.
Major new discoveries are necessary to fully understand this phenomenon and its underlying mechanisms. Our
proposed research program is focused on (1) determining whether splice isoform switching acts as a prevalent
mechanism that drives EMT or, if it is largely a phenomenon of byproducts; (2) understanding how RBPs
precisely control alternative splicing during EMT; and (3) dissecting how signaling cascades elicit signals to RBPs
and trigger alternative splicing changes during EMT. We have made major efforts in the past several years to
build up experimental systems and gain expertise to help carry out our proposed studies. These efforts include
large-scale RNA profiling of alternative splicing in multiple EMT systems, bioinformatics and experimental
analysis of RBPs, as well as our recently completed kinase screen for EMT-associated alternative splicing
alterations. Accomplishing the proposed work will provide new insights into our understanding of the regulatory
mechanisms of alternative splicing, thus contributing to biological relevance in normal development and diseases.
摘要
前mRNA的选择性剪接使基因能够产生多种不同的mRNA转录物,
产生具有不同甚至相反功能的蛋白质同种型。我们研究的长期目标是
了解选择性剪接的分子机制及其对生物活性的作用。的焦点
本研究旨在探讨上皮-间质转化(EMT)中选择性剪接的调控。
EMT是一个必不可少的发育过程,它使细胞从紧密堆积的鹅卵石状
从上皮细胞状态到能动的和梭形的间充质细胞状态。当异常激活时,
EMT促进许多类型的疾病,包括组织纤维化和癌症转移。通过在
RNA剪接和细胞生物学的交叉,我的实验室已经取得了几个重要的发现连接RNA
法规和EMT。我们的工作首次揭示了CD 44基因的剪接异构体转换与CD 44基因的转录水平有关。
控制急救人员。通过操纵CD 44选择性剪接,我们能够将上皮细胞和非上皮细胞之间的细胞转化为上皮细胞。
和间充质状态。我们还确定了RNA结合蛋白(RBP)hnRNPM作为关键剪接
通过调节选择性剪接促进EMT的因子。这些结果表明,RNA剪接
调节可以作为提供细胞可塑性的重要机制。通过改变
通过选择性剪接,细胞能够在上皮细胞状态和间充质细胞状态之间转换。这
逆转表型的能力对于正常发育的EMT以及对于癌症转移是重要的。
要充分理解这一现象及其潜在机制,就必须有重大的新发现。我们
建议的研究计划集中在(1)确定剪接异构体转换是否作为一种普遍的
驱动EMT的机制,或者,如果它在很大程度上是一种副产品的现象;(2)了解RBP如何
精确控制EMT过程中的选择性剪接;(3)剖析信号级联如何引发信号到RBP
并在EMT期间触发可变剪接变化。过去几年,我们作出了重大努力,
建立实验系统并获得专业知识,以帮助开展我们提出的研究。这些努力包括
多EMT系统中可变剪接的大规模RNA分析、生物信息学和实验
RBP的分析,以及我们最近完成的EMT相关可变剪接的激酶筛选
改变。完成拟议的工作将为我们理解监管提供新的见解,
选择性剪接的机制,从而有助于正常发育和疾病的生物相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chonghui Cheng其他文献
Chonghui Cheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chonghui Cheng', 18)}}的其他基金
Mechanisms of tumor cell clustering in breast cancer metastasis
肿瘤细胞聚集在乳腺癌转移中的机制
- 批准号:
10744976 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Regulation of alternative splicing during epithelial-mesenchymal transition
上皮间质转化过程中选择性剪接的调节
- 批准号:
10594525 - 财政年份:2019
- 资助金额:
$ 7.54万 - 项目类别:
Regulation of alternative splicing during epithelial-mesenchymal transition
上皮间质转化过程中选择性剪接的调节
- 批准号:
9901593 - 财政年份:2019
- 资助金额:
$ 7.54万 - 项目类别:
Regulation of alternative splicing during epithelial-mesenchymal transition
上皮间质转化过程中选择性剪接的调节
- 批准号:
10364651 - 财政年份:2019
- 资助金额:
$ 7.54万 - 项目类别:
Regulation of alternative splicing during epithelial-mesenchymal transition
上皮间质转化过程中选择性剪接的调节
- 批准号:
10712743 - 财政年份:2019
- 资助金额:
$ 7.54万 - 项目类别:
R35 Admin Diversity Supplement: Regulation of alternative splicing during epithelial-mesenchymal transition
R35 管理多样性补充:上皮-间质转化过程中选择性剪接的调节
- 批准号:
10720983 - 财政年份:2019
- 资助金额:
$ 7.54万 - 项目类别:
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
研究CD44s剪接亚型在乳腺癌转移中的机制
- 批准号:
9001950 - 财政年份:2014
- 资助金额:
$ 7.54万 - 项目类别:
Mechanisms of hnRNPM in Alternative Splicing Regulation During EMT
hnRNPM 在 EMT 期间选择性剪接调控的机制
- 批准号:
8673352 - 财政年份:2014
- 资助金额:
$ 7.54万 - 项目类别:
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
研究CD44s剪接亚型在乳腺癌转移中的机制
- 批准号:
8615683 - 财政年份:2014
- 资助金额:
$ 7.54万 - 项目类别:
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
研究CD44s剪接亚型在乳腺癌转移中的机制
- 批准号:
9312590 - 财政年份:2014
- 资助金额:
$ 7.54万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 7.54万 - 项目类别:














{{item.name}}会员




